1. Home
  2. IMCC vs SLXN Comparison

IMCC vs SLXN Comparison

Compare IMCC & SLXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMCC
  • SLXN
  • Stock Information
  • Founded
  • IMCC 1980
  • SLXN 2008
  • Country
  • IMCC Israel
  • SLXN Israel
  • Employees
  • IMCC N/A
  • SLXN N/A
  • Industry
  • IMCC Medicinal Chemicals and Botanical Products
  • SLXN
  • Sector
  • IMCC Health Care
  • SLXN
  • Exchange
  • IMCC Nasdaq
  • SLXN NYSE
  • Market Cap
  • IMCC 7.5M
  • SLXN 5.0M
  • IPO Year
  • IMCC N/A
  • SLXN N/A
  • Fundamental
  • Price
  • IMCC $2.21
  • SLXN $1.27
  • Analyst Decision
  • IMCC
  • SLXN Strong Buy
  • Analyst Count
  • IMCC 0
  • SLXN 1
  • Target Price
  • IMCC N/A
  • SLXN $9.00
  • AVG Volume (30 Days)
  • IMCC 15.7K
  • SLXN 31.9M
  • Earning Date
  • IMCC 03-27-2025
  • SLXN 02-25-2025
  • Dividend Yield
  • IMCC N/A
  • SLXN N/A
  • EPS Growth
  • IMCC N/A
  • SLXN N/A
  • EPS
  • IMCC N/A
  • SLXN N/A
  • Revenue
  • IMCC $38,042,859.00
  • SLXN N/A
  • Revenue This Year
  • IMCC $22.59
  • SLXN N/A
  • Revenue Next Year
  • IMCC $32.86
  • SLXN N/A
  • P/E Ratio
  • IMCC N/A
  • SLXN N/A
  • Revenue Growth
  • IMCC N/A
  • SLXN N/A
  • 52 Week Low
  • IMCC $1.61
  • SLXN $0.21
  • 52 Week High
  • IMCC $8.10
  • SLXN $13.56
  • Technical
  • Relative Strength Index (RSI)
  • IMCC 47.03
  • SLXN N/A
  • Support Level
  • IMCC $2.11
  • SLXN N/A
  • Resistance Level
  • IMCC $2.42
  • SLXN N/A
  • Average True Range (ATR)
  • IMCC 0.18
  • SLXN 0.00
  • MACD
  • IMCC 0.01
  • SLXN 0.00
  • Stochastic Oscillator
  • IMCC 29.09
  • SLXN 0.00

About IMCC IM Cannabis Corp.

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

About SLXN BIOMOTION SCIENCES

Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.

Share on Social Networks: